Indications |
Oral Giardiasis Adult: As hydrochloride: 100 mg tid for 5-7 days. Child: As hydrochloride: 2 mg/kg tid for 5-7 days. Max dose: 300 mg daily. Oral Lupus erythematosus Adult: As hydrochloride: 100 mg once a day for the first 1-2 mth. Maintenance dose: Reduce to 25-50 mg once a day several times a wk, although occasional management with 100-200 mg once daily may be required. Child: As hydrochloride: 1-2 mg/kg, up to 100 mg/day. Max dose: 100 mg daily. Intrapleural Prophylaxis of pneumothorax Adult: As hydrochloride: 100 mg instilled once a day for 3-4 consecutive days. |
Contraindications |
Hypersensitivity; psoriasis. |
Warnings / Precautions |
Elderly, history of psychosis, hepatic disease, porphyria. Pregnancy and lactation. |
Adverse Reactions |
Dizziness, headache; nausea, vomiting; reversible yellow discolouration of the skin, conjunctiva, urine (on prolonged use); blue-black discolouration of the palate and nails; psychosis, CNS stimulation, convulsions; ocular toxicity chronic dermatoses; rarely, liver toxicity and aplastic anaemia. |
Overdose Reactions |
Symptoms: Seizures, hypotension,cardiac arrhythmia, cardiovascular collapse. Management: Gastric lavage or induction of emesis. Symptomatic and supportive. |
Drug Interactions |
May produce disulfiram-type reaction with alcohol. May increase plasma concentrations and toxicity of primaquine. See Below for More mepacrine Drug Interactions |
Mechanism of Actions |
Mepacrine is a 9-aminoacridine antiprotozoal agent. It is used in the treatment of giardiasis (as an alternative to the nitroimidazoles), treatment of discoid and SC lupus erythematosus, and prophylaxis of pneumothorax (as an sclerosing agent). Its use for nonsurgical sterilisation in some countries is controversial and it was formerly used as an antimalarial agent. One suggested mechanism for its antiparasitic action is binding to DNA thereby inhibiting RNA transcription and translation. Absorption: Absorbed rapidly from GI tract (oral); absorbed rapidly after intrapleural and intrauterine admin. Peak plasma levels after 8-12 hr. Distribution: Widely distributed in body tissues. Crosses the placenta and distributes in breast milk. Protein-binding: 80-90%. Excretion: Via urine (<11%); via faeces; small amounts excreted in bile, sweat and saliva. |
Storage Conditions |
Oral: Store at 15-30°C (59-86°F). |
ATC Classification |
P01AX05 - mepacrine ; Belongs to the class of other agents used in the treatment amoebiasis and other protozoal diseases. |
Storage |
Oral: Store at 15-30°C (59-86°F). |
Available As |
|
Mepacrine
Post Review about Mepacrine Click here to cancel reply.
Mepacrine Containing Brands
Mepacrine is used in following diseases
Drug - Drug Interactions of Mepacrine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.